216 related articles for article (PubMed ID: 23911772)
21. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
[TBL] [Abstract][Full Text] [Related]
22. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):70-3. PubMed ID: 19359282
[TBL] [Abstract][Full Text] [Related]
23. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
24. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers.
Lee HY; Jeong JY; Lee KS; Kim HJ; Han J; Kim BT; Kim J; Shim YM; Kim JH; Song I
Radiology; 2012 Sep; 264(3):884-93. PubMed ID: 22829686
[TBL] [Abstract][Full Text] [Related]
25. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
[TBL] [Abstract][Full Text] [Related]
26. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
[TBL] [Abstract][Full Text] [Related]
27. Prediction of pathologic prognostic factors in patients with lung adenocarcinomas: comparison of thin-section computed tomography and positron emission tomography/computed tomography.
Iwano S; Kishimoto M; Ito S; Kato K; Ito R; Naganawa S
Cancer Imaging; 2014 Apr; 14(1):3. PubMed ID: 25609076
[TBL] [Abstract][Full Text] [Related]
28. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
[No Abstract] [Full Text] [Related]
29. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
[TBL] [Abstract][Full Text] [Related]
30. Multivariate analysis based on the maximum standard unit value of
Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
[TBL] [Abstract][Full Text] [Related]
31. Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Zhang L; Higashi K; Ishigaki Y; Ueda Y; Sakuma T; Takegami T; Oguchi M; Xu K; Ohta Y; Nishida H; Tonami H
Ann Nucl Med; 2010 Aug; 24(7):533-40. PubMed ID: 20607627
[TBL] [Abstract][Full Text] [Related]
32. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
33. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
[TBL] [Abstract][Full Text] [Related]
34. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
[TBL] [Abstract][Full Text] [Related]
36. Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
Soldath P; Binderup T; Kjaer A; Knigge U; Langer SW; Petersen RH
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38305412
[TBL] [Abstract][Full Text] [Related]
37. 18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.
Huang P; Zhao X; Xiao W; Dong Y; Hu G
Oncotarget; 2017 Jun; 8(24):39618-39626. PubMed ID: 28489603
[TBL] [Abstract][Full Text] [Related]
38. The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.
Kim HR; Kim DJ; Lee WW; Jheon S; Sung SW
Eur J Cardiothorac Surg; 2009 Apr; 35(4):712-6; discussion 716-7. PubMed ID: 19211260
[TBL] [Abstract][Full Text] [Related]
39. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
40. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]